FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-140 | 69194-140-01 | Bromfenac Sodium; Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | .35 mg/1 mL; 5 mg/1 mL; 1 mg/1 mL | 2026-1 | valid | 2026-10-06 | ||
| Pine Pharmaceuticals LLC | 69194-140 | 69194-140-01 | 140 CATARACTIVE MDB DROPS 0.5%-0.1%-0.035% 5mL | MOXIFLOXACIN 0.5%, DEXAMETHASONE 0.1%, BROMFENAC 0.035% | .35 mg/1 mL; 5 mg/1 mL; 1 mg/1 mL | 2026-1 | valid | 2026-09-18 | |
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-140 | 69194-140-01 | Bromfenac Sodium; Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | .35 mg/1 mL; 5 mg/1 mL; 1 mg/1 mL | 2025-2 | valid | 2026-10-06 | ||
| Pine Pharmaceuticals LLC | 69194-140 | 69194-140-01 | 140 CATARACTIVE MDB DROPS 0.5%-0.1%-0.035% 5mL | MOXIFLOXACIN 0.5%, DEXAMETHASONE 0.1%, BROMFENAC 0.035% | .35 mg/1 mL; 5 mg/1 mL; 1 mg/1 mL | 2025-2 | valid | 2026-09-18 |